Applied BioCode Corporation (6598.TW)

TWD 19.65

(3.97%)

Net Income Summary of Applied BioCode Corporation

Applied BioCode Corporation's latest annual net income in 2023 was -164.19 Million TWD , up 11.12% from previous year.
Applied BioCode Corporation's latest quarterly net income in 2024 Q2 was -50 Million TWD , up 20.77% from previous quarter.
Applied BioCode Corporation reported an annual net income of -184.73 Million TWD in 2022, down -11.82% from previous year.
Applied BioCode Corporation reported an annual net income of -165.19 Million TWD in 2021, down -59.62% from previous year.
Applied BioCode Corporation reported a quarterly net income of -63.12 Million TWD for 2024 Q1, down -635.84% from previous quarter.
Applied BioCode Corporation reported a quarterly net income of -8.57 Million TWD for 2023 Q4, up 80.38% from previous quarter.

Annual Net Income Chart of Applied BioCode Corporation (2023 - 2013)

Historical Annual Net Income of Applied BioCode Corporation (2023 - 2013)

Year	Net Income	Net Income Growth
2023	-164.19 Million TWD	11.12%
2022	-184.73 Million TWD	-11.82%
2021	-165.19 Million TWD	-59.62%
2020	-103.49 Million TWD	63.05%
2019	-280.07 Million TWD	-4.39%
2018	-268.3 Million TWD	-1.84%
2017	-263.46 Million TWD	-93.9%
2016	-135.87 Million TWD	-539.06%
2015	-21.26 Million TWD	70.13%
2014	-71.17 Million TWD	65.79%
2013	-208.02 Million TWD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-50 Million TWD	20.77%
2024 Q1	-63.12 Million TWD	-635.84%
2023 Q4	-8.57 Million TWD	80.38%
2023 FY	-164.19 Million TWD	11.12%
2023 Q1	-50.72 Million TWD	-41.38%
2023 Q2	-61.16 Million TWD	-20.57%
2023 Q3	-43.73 Million TWD	28.5%
2022 FY	-184.73 Million TWD	-11.82%
2022 Q1	-73.82 Million TWD	-189.83%
2022 Q4	-35.88 Million TWD	20.1%
2022 Q3	-44.9 Million TWD	-42.19%
2022 Q2	-31.58 Million TWD	57.22%
2021 Q4	-25.47 Million TWD	58.31%
2021 Q2	-54.71 Million TWD	-128.8%
2021 Q1	-23.91 Million TWD	-150.34%
2021 FY	-165.19 Million TWD	-59.62%
2021 Q3	-61.09 Million TWD	-11.66%
2020 FY	-103.49 Million TWD	63.05%
2020 Q4	47.5 Million TWD	305.93%
2020 Q3	-23.07 Million TWD	72.26%
2020 Q2	-83.15 Million TWD	-85.73%
2020 Q1	-44.77 Million TWD	22.1%
2019 Q3	-68.92 Million TWD	12.51%
2019 FY	-280.07 Million TWD	-4.39%
2019 Q1	-74.88 Million TWD	-10.16%
2019 Q2	-78.78 Million TWD	-5.2%
2019 Q4	-57.47 Million TWD	16.62%
2018 Q2	-61.29 Million TWD	0.0%
2018 FY	-268.3 Million TWD	-1.84%
2018 Q4	-67.98 Million TWD	12.55%
2018 Q3	-77.73 Million TWD	-26.83%
2018 Q1	-61.29 Million TWD	-1.01%
2017 Q3	-60.67 Million TWD	14.6%
2017 Q2	-71.05 Million TWD	0.0%
2017 Q4	-60.67 Million TWD	0.0%
2017 Q1	-71.05 Million TWD	0.0%
2017 FY	-263.46 Million TWD	-93.9%
2016 Q4	- TWD	0.0%
2016 Q2	-47.35 Million TWD	0.0%
2016 FY	-135.87 Million TWD	-539.06%
2015 FY	-21.26 Million TWD	70.13%
2015 Q4	- TWD	0.0%
2014 FY	-71.17 Million TWD	65.79%
2013 FY	-208.02 Million TWD	0.0%

Peer Net Income Comparison of Applied BioCode Corporation

Name	Net Income	Net Income Difference
Excelsior Medical Co., Ltd.	746.6 Million TWD	121.993%
Apex Medical Corp.	152.17 Million TWD	207.904%
OK Biotech Co., Ltd.	2.94 Million TWD	5669.844%